Depicting medullary thyroid cancer recurrence: the past and the future of nuclear medicine imaging.
about
Cabozantinib for progressive metastatic medullary thyroid cancer: a reviewConsensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI).Diagnostic utility of PET/CT with 18F-DOPA and 18F-FDG in persistent or recurrent medullary thyroid carcinoma: the importance of calcitonin and carcinoembryonic antigen cutoff.Recent Development of Nuclear Molecular Imaging in Thyroid Cancer.The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the “evidence-based” refusal to endorse them by EANM due to the “not evidence-based” marginalization of the role of Nuclear Medicine
P2860
Depicting medullary thyroid cancer recurrence: the past and the future of nuclear medicine imaging.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Depicting medullary thyroid ca ...... e of nuclear medicine imaging.
@en
type
label
Depicting medullary thyroid ca ...... e of nuclear medicine imaging.
@en
prefLabel
Depicting medullary thyroid ca ...... e of nuclear medicine imaging.
@en
P2860
P356
P1476
Depicting medullary thyroid ca ...... e of nuclear medicine imaging.
@en
P2093
Evangelia Skoura
P2860
P356
10.5812/IJEM.8156
P577
2013-10-01T00:00:00Z